Pharmaceuticals, Biotechnology and Life Sciences
If approved, lecanemab would be the first and only anti-amyloid treatment in Japan to offer an at-home injection from the…
The pioneer method combines the nitrosation assay procedure (NAP) with 15N-enriched nitrosating reagents and 15N NMR spectroscopy for a safer…
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), November 27, 2025 – GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to…
New name reflects company’s transformation as it advances toward the final phase of Lybrido™’s clinical development The Arletta butterfly symbolism…
Recognizes the company’s continued investment and expansion of cell therapy manufacturing and R&D operations in Ghent, reinforcing Flanders’ position as…
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, Nov. 27, 2025 (GLOBE…
Company announcement no. 11 – 25 27 November 2025 Change of management at NTG Nordic Transport Group A/S Appointment of…
Reference is made to the stock exchange announcement made by Zelluna ASA (the “Company”) on 3 November 2025 regarding the…
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 27 NOVEMBER 2025 at…
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 27, 2025 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13)…